The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease.
Saved in:
| Title: | The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease. |
|---|---|
| Authors: | Ehlers, Lars Holger1 (AUTHOR), Lamotte, Mark2 (AUTHOR), Monteiro, Sofia3 (AUTHOR), Sandgaard, Susanne4 (AUTHOR), Holmgaard, Pia4 (AUTHOR), Frary, Evan C.4 (AUTHOR), Ejskjaer, Niels1,5,6 (AUTHOR) n.ejskjaer@rn.dk |
| Source: | Diabetes Therapy. May2021, Vol. 12 Issue 5, p1523-1534. 12p. |
| Database: | Academic Search Ultimate |
| ISSN: | 18696953 |
|---|---|
| DOI: | 10.1007/s13300-021-01040-y |
